Nanomechanical testing for early breast lesions
Official title: ARTIDIS Nanomechanical Generated Measurements for Early Breast Lesions (ANGEL)
Run by Artidis Ag · NCT06085833 · Data updated 2026-11-12
This study is testing a new method using tiny mechanical measurements to see if it can better predict the type and severity of breast tumors in patients with suspicious breast lesions.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 2706 (estimated) |
| Sponsor | Artidis Ag Industry-sponsored |
| Locations | 6 sites (Dallas, Texas and 5 other locations) |
| Status | Recruiting |
| Started | November 2, 2023 |
| Main results expected | December 2026 |
| Study ends | November 2035 |
| Registry record updated | September 22, 2026 |
| Trial ID | NCT06085833 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients aged 18 and older who are referred for a breast biopsy due to suspicious lesions.
✕Probably not a fit
Patients with conditions that may render them unsuitable for the study, as determined by the investigator, will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective, blinded, single-arm study evaluates the effectiveness of nanomechanical phenotype tests in predicting tumor type, aggressiveness, and treatment response in patients with suspicious breast lesions. Participants will undergo standard breast biopsy procedures, and the nanomechanical measurements will be compared to traditional histopathological assessments. The study aims to enhance diagnostic accuracy and treatment planning for breast cancer patients by utilizing innovative nanomechanical technology.
Why it matters
Potential benefit: If successful, this approach could lead to more accurate and timely diagnoses of breast cancer, improving treatment outcomes for patients.
How similar studies have gone: While this approach is innovative, similar studies using advanced diagnostic techniques have shown promise in improving cancer detection and characterization.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged ≥ 18 years * Ability to understand and the willingness to sign a written informed consent. * Indication for breast biopsy for diagnostic purposes * ECOG performance status of 0 to 3. Exclusion Criteria: * Conditions that, in the investigator's opinion, might indicate that the subject is not suitable for the study.
Where it's running
-
University of Texas Southwestern Medical Center
Dallas, Texas, United States Recruiting -
Baylor College of Medicine
Houston, Texas, United States Recruiting -
MD Anderson Cancer Clinic - Mays Clinic
Houston, Texas, United States Recruiting -
University of Washington
Seattle, Washington, United States Recruiting -
Hospital Universitario Vall d'Hebron
Barcelona, Barcelona, Spain Recruiting -
Claraspital
Basel, Basel, Switzerland Active not recruiting
Study contacts
- Principal investigator: Alastair Thompson, MD — Baylor College of Medicine
- Study coordinator: Julia Ortega, DMSc, MHS, PA
- Email: julia.ortega@artidis.com
- Phone: 2404980176
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Gyrotonic exercise for elders with breast cancer and Behcet disease
We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.
-
PECS II vs SPSIP nerve blocks for pain after mastectomy
This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.
-
CG-7321: a first-in-human test in advanced solid tumors
We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.
-
Compare a new endoscopy-assisted breast-conserving surgery with the usual approach
This study tests whether a new endoscopy-assisted breast-conserving technique can provide similar or better cosmetic outcomes and safety compared with conventional breast-conserving surgery in women with early breast cancer who want to preserve their breast.
-
Different skin care approaches to prevent skin reactions after mastectomy radiation
This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.
-
3D Heart Strain to Detect Early Cardiotoxicity in Cancer Therapy
This study tests whether 3D echocardiography can detect early heart damage from cancer treatments like anthracyclines or HER2-targeted therapy better than standard 2D methods.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.